Mindbloom vs. BetterU: Which Ketamine Therapy Is Right for You?

Quick Summary

Ketamine has been an FDA-approved anesthetic since 1970 and a fixture on the World Health Organization's List of Essential Medicines since 1985. Today, licensed clinicians widely prescribe it off-label for mental health conditions.⁷

When comparing at-home providers, Mindbloom offers a defined treatment framework backed by peer-reviewed outcomes data. It features both subcutaneous and sublingual options alongside a full support ecosystem.

BetterU provides a telehealth prescribing service centered on medication access. Choosing between them depends on whether you seek a comprehensive therapeutic process or a streamlined medication service.

Mindbloom vs BetterU at a Glance

What Is At-Home Ketamine Therapy?

At-home ketamine therapy is a clinician-prescribed, self-administered treatment conducted in your own home under remote clinical supervision. This model is distinct from in-clinic IV infusions or Spravato (esketamine), which must be administered in a certified healthcare setting.

A licensed clinician evaluates you via telehealth and prescribes compounded ketamine. You then take the medication at home with a support person present.

These sessions are part of a broader treatment protocol that typically includes preparation, the dosing session itself, and integration afterward. Ketamine temporarily modulates NMDA receptor activity and increases glutamate signaling in the brain.

Research suggests this process promotes neuroplasticity, which is the brain's ability to form new neural connections and adapt to new information. At-home models have significantly expanded access to ketamine therapy for people who lack proximity to infusion clinics or prefer the comfort of a familiar environment.

Multiple peer-reviewed studies have evaluated the safety and effectiveness of this setting. A typical at-home ketamine therapy program includes:

• Clinical evaluation: A telehealth consultation with a licensed prescriber to assess your medical history, diagnosis, and whether at-home ketamine is medically appropriate within the provider's clinical protocol.
• Prescribed medication: Compounded ketamine in sublingual or subcutaneous form, shipped directly to your home.
• Guided sessions: Dosing sessions conducted at home with a peer treatment monitor present.
• Integration support: Post-session practices like journaling, coaching, and group sessions designed to help translate insights into lasting change.

How Does At-Home Ketamine Compare to In-Clinic Infusion?

In-clinic IV ketamine is administered intravenously in a medical office with on-site monitoring by healthcare staff. At-home ketamine uses sublingual or subcutaneous routes in your own environment with remote clinical oversight and an in-person peer treatment monitor.

IV administration offers the highest bioavailability at approximately 100% and allows for precise dose titration. Subcutaneous administration offers high bioavailability with a faster onset than sublingual, while sublingual is needle-free with somewhat more variable absorption.

In-clinic sessions typically last 40 to 60 minutes with mandatory on-site observation time. At-home sessions allow you to remain in a familiar, comfortable setting throughout the entire experience and the post-session transition.

Direct comparisons across treatment modalities should be interpreted with caution due to differences in study design, patient populations, and outcome measures. However, treatment setting does not inherently determine effectiveness when protocols are clinically supervised.

Mindbloom's peer-reviewed outcomes demonstrate symptom improvement rates comparable to those reported in selected published IV ketamine studies.¹ ⁵

How Mindbloom Works

Mindbloom is one of the largest providers of guided at-home ketamine therapy in the United States. The company offers comprehensive programs of 6, 12, or 18 sessions.

Mindbloom provides both sublingual tablets and subcutaneous injectables, allowing for personalized care based on clinical needs. Each program is designed so that ketamine is delivered as part of a guided therapeutic process, rather than as a standalone prescription.

Every treatment plan includes clinician consults for diagnosis, prescribing, and ongoing dosage management. Clients also receive one-on-one guide coaching sessions for preparation and integration, unlimited guide messaging, and access to unlimited Group Integration Circles.

A peer treatment monitor is required to be present during every session to ensure safety and support. Treatment frequency is personalized based on clinical guidance and individual progress.

Sessions may be more frequent initially to build therapeutic momentum, then adjusted over time. The combination of clinical oversight, coaching, integration, and community support distinguishes this program-based approach from a prescription-only model.

A standard Mindbloom program includes:

• Clinician consults: Licensed prescribers assess medical appropriateness, prescribe medication when clinically indicated, and manage dosing across the program.
• Guide coaching: One-on-one sessions focused on preparation before and integration after ketamine sessions.
• Unlimited guide messaging: Ongoing asynchronous support between your scheduled sessions.
• Group Integration Circles: Peer-led community sessions for shared reflection and accountability.
• Bloombox: A physical kit containing an eye mask, journal, and session essentials.
• Mindbloom App: Guides each step of the process with programs, soundscapes, and tracking tools.
• Two administration options: Sublingual tablets (needle-free) and subcutaneous injectables (higher bioavailability).

How BetterU Works

BetterU is an online ketamine therapy provider offering telehealth-based prescribing and at-home treatment for depression, anxiety, and PTSD. Patients complete an initial intake assessment and meet with a prescriber via telehealth to assess whether at-home ketamine is medically appropriate based on their symptoms, history, and risk factors.

If approved, patients receive compounded sublingual ketamine shipped directly to their home, with a nasal spray option available for patients who have already completed treatment with oral ketamine. BetterU's model is primarily oriented around the prescribing relationship and medication delivery.

While their core service is a streamlined telehealth model, BetterU does include 1-on-1 integration coaching and access to a Neuroplastic Therapy program featuring personalized routines and therapeutic exercises rooted in CBT and psychodynamic approaches. BetterU requires a peer support person to be present during sessions.

As of the time of writing, BetterU has not published peer-reviewed outcomes data on their own clinical protocol. This means there is no independent verification of their specific model's safety and effectiveness in a real-world setting.

Key Differences Between Mindbloom and BetterU

While both companies provide access to at-home ketamine therapy, their approaches to care differ significantly. The quality of a ketamine therapy experience depends not just on the medication, but on the clinical infrastructure surrounding it.

Clinical Evidence and Published Research

Published research on a provider's own protocol means that peer-reviewed studies were conducted on their actual patient population using their specific clinical framework. This is distinct from simply referencing general ketamine literature.

Mindbloom has published two of the largest peer-reviewed, real-world outcomes studies of at-home ketamine therapy to date in the Journal of Affective Disorders.¹ ² These studies, conducted on Mindbloom clients, demonstrate an 89% improvement rate for anxiety and a 56 to 63% depression response rate.

The safety profile shows side effects occurring in approximately 4 to 5% of sessions, with serious adverse events at fewer than 0.1%. BetterU has not published peer-reviewed outcomes data on their own protocol.

Care Model and Support Structure

Ketamine therapy providers range from prescription-only models to full-program models that embed medication within a therapeutic framework. Mindbloom provides clinician consults, one-on-one guide coaching, unlimited guide messaging, and unlimited Group Integration Circles.

These elements are all designed to support preparation, the session itself, and integration afterward. BetterU includes 1-on-1 integration coaching and a Neuroplastic Therapy program, though its overall model is built around a smaller number of structured touchpoints.

The depth of the support structure affects not just the immediate experience, but potentially the durability of outcomes. Integration—the process of translating session insights into lasting behavioral change—is where much of the long-term therapeutic value is generated.

Administration Methods and Options

The primary administration routes available in at-home ketamine therapy are sublingual (a tablet held in the mouth) and subcutaneous (a small injection into the abdomen). As of this writing, Mindbloom is the only at-home ketamine provider offering both sublingual tablets and subcutaneous injectables.

The subcutaneous option provides higher bioavailability and faster onset, similar to IV administration but in a home setting. BetterU offers sublingual tablets as its primary option, with a nasal spray available for patients who have previously completed treatment with oral ketamine.

Presenting both sublingual and subcutaneous options allows clinicians to tailor the treatment to individual needs and preferences. Sublingual is needle-free and comfortable, while subcutaneous offers more consistent session intensity and higher absorption.

Cost, Insurance, and Accessibility

At-home ketamine therapy is generally not covered by insurance, though some providers offer HSA/FSA eligibility and superbills for potential out-of-network reimbursement. Mindbloom utilizes a program-based pricing structure paid in monthly installments.

For a new client 6-session program, the cost is $430 per month for 3 months, totaling $1,290. This price includes not just the medication, but the full support ecosystem of clinician oversight, coaching, and integration.

BetterU generally offers a lower sticker price per session, reflecting its medication-focused model. When comparing cost, it is important to consider what is included in the treatment plan.

Mindbloom remains approximately 60% more affordable per session than in-clinic IV ketamine infusions.

Safety Protocols and Screening

Safety infrastructure in at-home ketamine therapy relies on clinical screening, session monitoring, and ongoing oversight. Mindbloom requires a peer treatment monitor to be present during every session and conducts rigorous clinician-led screening for cardiovascular and psychiatric contraindications.

Mindbloom also provides 24/7 live chat support and has published safety data showing serious adverse events occur in fewer than 0.1% of sessions. BetterU utilizes standard telehealth screening and requires a peer support person to be present during sessions.

The FDA has issued guidance noting that compounded ketamine products are not FDA-approved for psychiatric indications and may involve risks such as dosing variability, sedation, dissociation, blood pressure changes, misuse, and medication errors, including in at-home use.⁸ This applies to all providers using compounded ketamine, not uniquely to any one.

Compounding pharmacies are a standard, regulated part of U.S. healthcare.⁹ What distinguishes providers from one another is the clinical infrastructure and safety protocols each builds around the medication.

Mindbloom Outcomes: What the Published Research Shows

This section covers specific, quantified results from Mindbloom's peer-reviewed studies and clinical analyses. These studies build on decades of clinical research supporting ketamine's therapeutic applications.

Direct comparisons across treatment modalities should be interpreted with caution due to differences in study design, patient populations, and outcome measures.

• Depression: In a peer-reviewed study of 11,441 patients, 89% of clients reported improvement in their symptoms, and 56.4% met criteria for response measured by the PHQ-9.² Mindbloom's reported depression response rates exceed response rates reported in selected meta-analyses of talk therapy.³
• Anxiety: The same study demonstrated that 89% of participants reported improvement in their symptoms, with a 56.1% response rate measured by the GAD-7.²
• PTSD: In a real-world analysis of 374 ketamine therapy for PTSD program completers, 92.2% reported symptom improvement, and 79.7% met criteria for response measured by the PCL-5.⁴ Mindbloom's reported response rate exceeds response rates reported in selected randomized trials of prolonged exposure therapy for PTSD.⁶
• Safety: Across studies, adverse events were reported in approximately 4 to 5% of participants. Serious adverse events occurred in fewer than 0.1%, and the discontinuation rate was 0.4%.

These studies were conducted on Mindbloom clients using the Mindbloom clinical protocol. Individual results may vary. BetterU has not published peer-reviewed outcomes data on their own protocol.

Who Should Choose Mindbloom vs BetterU?

Choosing the right provider depends on your therapeutic goals, budget, and desired level of support. A licensed clinician will ultimately determine whether ketamine therapy is medically appropriate for you, regardless of which provider you choose.

Mindbloom may be right for you if:

• You want a comprehensive program that includes dedicated coaching and integration support.
• You value treatment backed by published, peer-reviewed outcomes data.
• You want the option to choose between sublingual tablets and subcutaneous injectables.
• You prefer a full support ecosystem, including 24/7 messaging and clinical oversight.
• You want access to a supportive community through Group Integration Circles.

BetterU may be right for you if:

• You prefer a streamlined, medication-first prescribing model.
• You are primarily seeking access to ketamine with lighter-touch clinical support.
• You are comfortable navigating the preparation and integration process with self-guided tools and 1-on-1 integration coaching.
• You are looking for a lower initial sticker price and do not require the full scope of Mindbloom's coaching and programming.

Disclaimer and Safety Information

IMPORTANT SAFETY INFORMATION
‍Ketamine is not FDA-approved for PTSD, depression, or anxiety. Common side effects include dissociation, increased blood pressure, nausea, dizziness, and cognitive impairment. Ketamine has abuse potential and is not appropriate for patients with uncontrolled hypertension, psychotic disorders, or substance use disorders. Do not drive or operate machinery until the day after treatment. Individual results may vary. Full safety information: www.mindbloom.com/safety-information

‍OFF-LABEL USE DISCLOSURE
‍Ketamine is FDA-approved only as an anesthetic. Use for mental health conditions represents off-label prescribing by licensed clinicians based on clinical judgment. Schedule III Controlled Substance - DEA regulations apply.